Table 2.

The percentage of donor-derived Ly5.1+, myeloid (Mac1+ and Gr1+), and lymphoid (B220+ and CD3+) cells in the blood of mice 8 weeks after reconstitution with PCLP1+ or PCLP1- LSK cells


No. of Ly5.1+ cells injected

No. of recipient mice

Donor-derived myeloid cells, %

Donor-derived lymphoid cells, %
PCLP1+ LSK    
   500   1   3   20  
   50   1   1   18  
   10   4   2-7   0.5-20  
PCLP1- LSK    
   500   2   0.2-1   0.8-5  
   50   1   0.3   1.3  
   10   3   1-2   0.5-1  
Controls*
 
3
 
0
 
0
 

No. of Ly5.1+ cells injected

No. of recipient mice

Donor-derived myeloid cells, %

Donor-derived lymphoid cells, %
PCLP1+ LSK    
   500   1   3   20  
   50   1   1   18  
   10   4   2-7   0.5-20  
PCLP1- LSK    
   500   2   0.2-1   0.8-5  
   50   1   0.3   1.3  
   10   3   1-2   0.5-1  
Controls*
 
3
 
0
 
0
 
*

Control animals did not receive Ly5.1+ cells

Close Modal

or Create an Account

Close Modal
Close Modal